Trial intelligence / Profile preview

Perioperative Atosiban for Ultrasound-indicated Cerclage

NCT06537778Completed

Sponsor
Children's Hospital of Chongqing Medical University
Start
Jan 2018
Primary completion
Feb 2024
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Spontaneous Preterm Birth (SPB) comparing Atosiban with Placebo (2 arms). Primary endpoint: Rate of spontaneous Preterm Birth up to 34 weeks. Started Jan 2018; status: completed.

02

Drugs

atosiban
03

Conditions

Spontaneous Preterm Birth (SPB)

Beyond the preview

Go deeper on NCT06537778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06537778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call